Dr. Eggington co-founded the Center for Genomic Interpretation (CGI) in 2016, which became a nonprofit organization in 2017, with the mission to drive quality in clinical genetics. To accomplish its mission, CGI provides a variety of services to health insurers, laboratories, clinicians and patients. Dr. Eggington is an expert in the initial classification of novel clinical genetic variants, high throughput literature curation, as well as the accurate re-classification of Variants of Uncertain Significance (VUS) through optimized research methods. Dr. Eggington has directed variant classification and reclassification programs at Myriad Genetics, Courtagen, and 23andMe. Dr. Eggington received her Ph.D. in Biochemistry from the University of Wisconsin-Madison, her M.S. from the University of Utah, and her B.S. from Brigham Young University.
Clinical Dx Showcase: Center for Genomic Interpretation
CGI’s mission is to drive quality in clinical genetics by providing services to insurers, labs, clinicians & patients.
Improving Genetic Testing Reimbursement Through Quality Transparency
Health insurers are struggling to adapt to precision medicine reimbursement requests. CGI’s ELEVATEGenetics initiative is designed to provide insurers with standardized quality metrics from genetics labs that allow insurers to proceed with confidence in their reimbursements of quality tests.